Reynand Wu
- Women’s Empowerment
- October 22, 2026
- 10 views
The FDA’s Calculated Silence: Why the Strategic Delay on Mifepristone Matters
In the high-stakes theater of American reproductive politics, the Food and Drug Administration (FDA) has emerged as a central, if reluctant, protagonist. In a move that has drawn sharp criticism…
